Allergies News and Research

Latest Allergies News and Research

People with allergic conditions may have a lower risk of COVID-19 infection, finds study

People with allergic conditions such as hay fever, rhinitis, and atopic eczema, may have a lower risk of COVID-19 infection, especially if they also have asthma, finds a large, population-based study of UK adults, published online in the respiratory journal Thorax.

1 Dec 2021

Study uncovers major disparities in preferred HIV medication uptake in low- and middle-income countries

A new study uncovered large and persistent disparities by sex and age in the uptake of a preferred HIV medication in low- and middle-income countries, potentially subjecting some women to worse HIV treatment outcomes if the situation is not corrected quickly.

30 Nov 2021

Natural COVID-19 infection offers protection from gamma and delta variants of SARS-CoV-2

Natural infection with COVID-19 offered protection from reinfection when the gamma and delta variants predominated, according to a new University of Michigan study that also provides levels of antibodies needed to protect against reinfections.

30 Nov 2021

Substantial efforts needed to help people with HIV achieve durable viral suppression, study suggests

Among people with HIV worldwide who are receiving antiretroviral therapy (ART), adults are getting closer to the global target of 95% achieving viral suppression, but progress among children and adolescents is lagging and long-term viral suppression among all groups remains a challenge.

30 Nov 2021

Study suggests substantial efforts are needed to help people with HIV durably suppress the virus

30 Nov 2021

A review of natural immunity, vaccines, and variants in SARS-CoV-2 reinfection

In a literature review article published in the Journal of Community Hospital Internal Medicine Perspectives, authors from the US performed a thorough investigation of previous studies and case reports of SARS-CoV-2 reinfection. This review discusses the role of natural immunity, vaccines, and SARS-CoV-2 variants in reinfection.

25 Nov 2021

Treatment with antihistamines associated with improved responses to immunotherapy

New research from The University of Texas MD Anderson Cancer Center found that treatment with antihistamines, a commonly used allergy medication, was associated with improved responses to immune checkpoint inhibitors.

24 Nov 2021

Washington University joins international effort to support data science research and training in Africa

Washington University in St. Louis is joining a major international effort to advance data science, catalyze innovation and spur health discoveries across Africa.

21 Nov 2021

Delta-like SARS-CoV-2 variants with enhanced transmissibility may cause a more severe pandemic

A SARS-CoV-2 variant with traits similar to that of the Delta variant - enhanced transmissibility and an ability to infect people who had previous infections/vaccination - will cause a more severe pandemic with more infections and breakthrough infections/reinfections than variants with either trait alone, according to a mathematical model created by researchers at Harvard T.H. Chan School of Public Health.

21 Nov 2021

New evidence that host immunity drives evolution of the dengue virus

New research by a team of University of Florida investigators, and others, provides evidence that host immunity drives evolution of the dengue virus.

20 Nov 2021

Infant respiratory syncytial virus infection results in metabolic reprogramming of airway epithelial cells

Infection with respiratory syncytial virus during infancy results in metabolic reprogramming of epithelial cells lining the airway, according to a Northwestern Medicine study published in the journal Viruses.

20 Nov 2021

Researchers receive $22 million grant for clinical trial that aims to reduce lung transplant rejection

Physicians at Washington University School of Medicine in St. Louis and Massachusetts General Hospital/Harvard Medical School in Boston have received a seven-year, $22 million grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health to help lead a multicenter clinical trial evaluating whether a novel immunosuppressant can reduce the risk of organ rejection after a lung transplant.

18 Nov 2021

AI and whole genome sequencing improve quick detection of infectious disease outbreaks

By coupling machine learning with whole genome sequencing, University of Pittsburgh School of Medicine and Carnegie Mellon University scientists greatly improved the quick detection of infectious disease outbreaks within a hospital setting over traditional methods for tracking outbreaks.

17 Nov 2021

Lung autopsies provide a clearer picture of how SARS-CoV-2 virus spreads and causes damage

Lung autopsy and plasma samples from people who died of COVID-19 have provided a clearer picture of how the SARS-CoV-2 virus spreads and damages lung tissue.

17 Nov 2021

New guidebook provides a roadmap for navigating the challenges in telehealth

The Foundation for Research Development at the Medical University of South Carolina (MUSC) has partnered with The Stationery Office, a British publishing company, to develop a new guidebook titled TSIM: The Telehealth Framework.

15 Nov 2021

Long-term study begins to evaluate COVID-19's effects on the overall health of children

A large, long-term study of the impacts of COVID-19 on children has enrolled its first participant at the National Institutes of Health's Clinical Center in Bethesda, Maryland.

15 Nov 2021

ACTG announces launch of clinical trial evaluating a three-month TB treatment

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the launch of A5362 (CLO-FAST), a clinical trial studying a three-month clofazimine- and high-dose rifapentine-containing treatment regimen for people with drug-susceptible tuberculosis (TB).

10 Nov 2021

Allergies News and Research

Latest Allergies News and Research

People with allergic conditions may have a lower risk of COVID-19 infection, finds study

Study uncovers major disparities in preferred HIV medication uptake in low- and middle-income countries

Natural COVID-19 infection offers protection from gamma and delta variants of SARS-CoV-2

Substantial efforts needed to help people with HIV achieve durable viral suppression, study suggests

Study suggests substantial efforts are needed to help people with HIV durably suppress the virus

A review of natural immunity, vaccines, and variants in SARS-CoV-2 reinfection

Treatment with antihistamines associated with improved responses to immunotherapy

Washington University joins international effort to support data science research and training in Africa

Delta-like SARS-CoV-2 variants with enhanced transmissibility may cause a more severe pandemic

New evidence that host immunity drives evolution of the dengue virus

Infant respiratory syncytial virus infection results in metabolic reprogramming of airway epithelial cells

Researchers receive $22 million grant for clinical trial that aims to reduce lung transplant rejection

AI and whole genome sequencing improve quick detection of infectious disease outbreaks

Lung autopsies provide a clearer picture of how SARS-CoV-2 virus spreads and causes damage

New guidebook provides a roadmap for navigating the challenges in telehealth

Long-term study begins to evaluate COVID-19's effects on the overall health of children

ACTG announces launch of clinical trial evaluating a three-month TB treatment

Western boom cities see spike in harmful ozone

Scientists create a rapid diagnostic technology to detect SARS-CoV-2

Unexpected antibody discovery provides new insight into how the body responds to malaria infection

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Allergies News and Research

Latest Allergies News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in